Prisbind IV solution 2.5g by Nippon Boehringer Ingelheim contains Idarucizumab (genetical recombination). This injectable drug, YJ code 3399412A1027, is supplied as 2.5g in 50mL per bottle. Idarucizumab is a specific reversal agent for dabigatran, an anticoagulant.
Prisbind IV solution 2.5g
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
